Skip to content

Clinical trials

Phase 2 Adenocarcinoma of Lung trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma of Lung Phase: Phase 2 Country / region: United States Clear all

90 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20015
20025
20031
20045
20059
200610
20078
20085
20092
20102
20114
20123
20131
20142
20152
20162
20173
20192
20202
20212
20222
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed61
Terminated17
Active, not recruiting6
Recruiting4
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alliance for Clinical Trials in Oncology14
National Cancer Institute (NCI)13
SWOG Cancer Research Network11
Radiation Therapy Oncology Group5
Masonic Cancer Center, University of Minnesota3
Novartis Pharmaceuticals3
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins3
Case Comprehensive Cancer Center2
M.D. Anderson Cancer Center2
Memorial Sloan Kettering Cancer Center2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma of Lung90
Carcinoma, Non-Small-Cell Lung78
Lung Neoplasms72
Adenocarcinoma, Bronchiolo-Alveolar39
Colorectal Neoplasms2
Drug-Related Side Effects and Adverse Reactions2
Ovarian Neoplasms2
Pancreatic Neoplasms2
Pleural Effusion, Malignant2
Adrenocortical Carcinoma1

Trials

Showing 1 to 25 of 90. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.